Treatment of ventricular assist-device-associated gastrointestinal bleeding with hormonal therapy

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 27, Issue 5, 2013, Pages 939-943

  Gutsche, Jacob T ^a   Atluri, Pavan ^a   Augoustides, John G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

arteriovenous malformation; cardiac assist device; gastrointestinal bleeding; hormone therapy; ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; ETHINYLESTRADIOL; HEMOGLOBIN; HEPARIN; MILRINONE; NORETHISTERONE; OCTREOTIDE; VITAMIN K GROUP; WARFARIN;

AGED; ARTERIOVENOUS MALFORMATION; ARTICLE; CASE REPORT; CAUTERIZATION; ENDOSCOPY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HORMONAL THERAPY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; MALE; MELENA; NONISCHEMIC CARDIOMYOPATHY; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOEMBOLISM; TREATMENT OUTCOME;

ARTERIOVENOUS MALFORMATION; CARDIAC ASSIST DEVICE; GASTROINTESTINAL BLEEDING; HORMONE THERAPY; VENTRICULAR ASSIST DEVICE;

AGED; ETHINYL ESTRADIOL; GASTROINTESTINAL HEMORRHAGE; HEART-ASSIST DEVICES; HUMANS; MALE; NORETHINDRONE; POSTOPERATIVE HEMORRHAGE; TREATMENT OUTCOME;

EID: 84884510936     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2013.05.019     Document Type: Article

References (45)

1. S. Islam, C. Cevik, and R. Madonna Left ventricular assist devices and gastrointestinal bleeding: A narrative review of case reports and case series Clin Cardiol 36 2013 190 200
2. S. Crow, R. John, and A. Boyle Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices J Thorac Cardiovasc Surg 137 2009 208 215
3. D.R. Stern, J. Kazam, and P. Edwards Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD J Card Surg 25 2010 352 356
4. M.A. Grasso, J.M. Fenkel, and E.N. Sorensen Gastrointestinal bleeding from arteriovenous malformations in recipients of left ventricular assist devices J Cardiac Failure 13 2007 S115
5. C. Heilmann, U. Geisen, and C. Benk Haemolysis in patients with ventricular assist devices: Major differences between systems Eur J Cardiothorac Surg 36 2009 580 584
6. R. John Current axial-flow devices - The HeartMate II and Jarvik 2000 left ventricular assist devices Semin Thorac Cardiovasc Surg 20 2008 264 272
7. A. Garatti, G. Bruschi, and T. Colombo Noncardiac surgical procedures in patient supported with long-term implantable left ventricular assist device Am J Surg 197 2009 710 714
8. M.A. Siddiqui, M.S. Slaughter, and R.G. Silva Gastrointestinal complications in patients supported with ventricular assist devices Gastroenterology 136 2009 A213 A214
9. R. Hetzer, Y. Weng, and E.V. Potapov First experiences with a novel magnetically suspended axial flow left ventricular assist device Eur J Cardiothorac Surg 25 2004 964 970
10. I.W. Wang, T. Guthrie, and G.A. Ewald Gastrointestinal bleeding complications in continuous flow LVAD patients - Is it device specific? J Heart Lung Transplant 29 2009 S8
11. A.L. Meyer, D. Malehsa, and C. Bara Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device Circulation 3 2010 675 681
12. A. Aggarwal, R. Pant, and S. Kumar Incidence and management of gastrointestinal bleeding with continuous flow assist devices Ann Thorac Surg 93 2012 1534 1540
13. J.M. Schaffer, G.J. Arnaoutakis, and J.G. Allen Bleeding complications and blood product utilization with left ventricular assist device implantation Ann Thorac Surg 91 2011 740 747 discussion; 747-749
14. Z.T. Demirozu, R. Radovancevic, and L.F. Hochman Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device J Heart Lung Transplant 30 2011 849 853
15. J.A. Morgan, G. Paone, and H.W. Nemeh Gastrointestinal bleeding with the HeartMate II left ventricular assist device J Heart Lung Transplant 31 2012 715 718
16. R. John, F. Kamdar, and P. Eckman Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices Ann Thorac Surg 92 2011 1593 1599 discussion 1599-1600
17. N. Uriel, S.W. Pak, and U.P. Jorde Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation J Am Coll Cardiol 56 2010 1207 1213
18. M.L. Jessup, D. Goldstein, and D.D. Ascheim Risk for bleeding after MCSD implant: An analysis of 2358 patients in INTERMACS J Heart Lung Transplant 30 2011 S9
19. M. Attisani, P. Centofanti, and M. La Torre Safety and effectiveness of low dosing of double antiplatelet therapy during long-term left ventricular support with the INCOR system J Artif Organs 13 2010 202 206
20. E. Heyde Gastrointestinal bleeding in aortic stenosis - Letter N Eng J Med 259 1958 196-196
21. P. Batur, W.J. Stewart, and J.H. Isaacson Increased prevalence of aortic stenosis in patients with arteriovenous malformations of the gastrointestinal tract in Heyde syndrome Arch Intern Med 163 2003 1821 1824
22. A.B. Federici, J.H. Rand, and P. Bucciarelli Acquired von Willebrand syndrome: Data from an international registry Thromb Haemost 84 2000 345 349
23. A. Vincentelli, S. Susen, and T. Le Tourneau Acquired von Willebrand syndrome in aortic stenosis New Engl J Med 349 2003 343 349
24. G.V. Letsou, N. Shah, and I.D. Gregoric Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device J Heart Lung Transplant 24 2005 105 109
25. J.S. Barkin, and B.S. Ross Medical therapy for chronic gastrointestinal bleeding of obscure origin Am J Gastroenterol 93 1998 1250 1254
26. V.M. Kushnir, S. Sharma, and G.A. Ewald Evaluation of GI bleeding after implantation of left ventricular assist device Gastrointest Endosc 75 2012 973 979
27. O. Wever-Pinzon, C.H. Selzman, and S.G. Drakos Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II Circ Heart Fail 6 2013 517 526
28. M.S. Cappell, and O. Lebwohl Cessation of recurrent bleeding from gastrointestinal angiodysplasias after aortic valve replacement AnnI Intern Med 105 1986 54 57
29. J. Suarez, C.B. Patel, and G.M. Felker Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices Circulation 4 2011 779 784
30. U. Geisen, C. Heilmann, and F. Beyersdorf Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease Eur J Cardiothorac Surg 33 2008 679 684
31. M.S. Slaughter Hematologic effects of continuous flow left ventricular assist devices J Cardiovasc Transl Res 3 2010 618 624
32. J. Klovaite, F. Gustafsson, and S.A. Mortensen Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II) J Am Coll Cardiol 53 2009 2162 2167
33. H.M. Hayes, L.G. Dembo, and R. Larbalestier Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: A single-center experience Artif Organs 34 2010 703 706
34. B.J. Elmunzer, K.T. Padhya, and J.J. Lewis Endoscopic findings and clinical outcomes in ventricular assist device recipients with gastrointestinal bleeding Dig Dis Sci 56 2011 3241 3246
35. C.T. Meyer, F.J. Troncale, and S. Galloway Arteriovenous malformations of the bowel: An analysis of 22 cases and a review of the literature Medicine (Baltimore) 60 1981 36 48
36. L.S. Eriksson, and J. Wahren Intravenous and subcutaneous administration of a long-acting somatostatin analogue: Effects on glucose metabolism and splanchnic haemodynamics in healthy subjects Eur J Clin Inv 19 1989 213 219
37. C. Brown, V. Subramanian, and C.M. Wilcox Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: An overview and systematic review of prospective observational studies DigDis Sci 55 2010 2129 2134
38. Z.Z. Ge, H.M. Chen, and Y.J. Gao Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation Gastroenterology 141 2011 1629 1637 e1621-1624
39. H.J. Koch Jr, G.C. Escher, and J.S. Lewis Hormonal management of hereditary hemorrhagic talangiectasia JAMA 149 1952 1376 1380
40. E. van Cutsem, P. Rutgeerts, and G. Vantrappen Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone Lancet 335 1990 953 955
41. B.S. Lewis, P. Salomon, and S. Rivera-MacMurray Does hormonal therapy have any benefit for bleeding angiodysplasia? J Clin Gastroenterol 15 1992 99 103
42. F. Junquera, F. Feu, and M. Papo A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia Gastroenterology 121 2001 1073 1079
43. Y.K. Liu, R.E. Kosfeld, and S.G. Marcum Treatment of uraemic bleeding with conjugated oestrogen Lancet 2 1984 887 890
44. M.G. Menefee, H.C. Flessa, and H.I. Glueck Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). An electron microscopic study of the vascular lesions before and after therapy with hormones Arch Otolaryngol 101 1975 246 251
45. A. Szilagyi, and M.P. Ghali Pharmacological therapy of vascular malformations of the gastrointestinal tract Can J Gastroenterol 20 2006 171 178